Nian‐Yong Chen - Concepedia

Author

Nian‐Yong Chen

Also Known As

Nian-Yong Chen, Nian‐Yong Chen, Nian‐yong Chen

Publications

783

Citations

H-Index

Concepts

All Affiliations

Nian‐Yong Chen is an author at Sichuan University specializing in health sciences, radiation oncology, and oncology.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	2	2	122
2	Engineering	1	1	104
3	Medicine	1	1	18
4	Cancer Therapeutics	1	1	18
5	Clinical Trials	1	1	18

Nian‐Yong Chen

Publications

782

Citations

H-Index

Page 1

	Year	Citations
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma Ling‐Long Tang, Yu‐Pei Chen, Chuanben Chen, Cancer Communications	2021	374
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial Wen‐Fei Li, Nian‐Yong Chen, Ning Zhang, International Journal of Cancer	2019	240
Multi-subject atlas-based auto-segmentation reduces interobserver variation and improves dosimetric parameter consistency for organs at risk in nasopharyngeal carcinoma: A multi-institution clinical study Changjuan Tao, Junlin Yi, Nian‐Yong Chen, Radiotherapy and Oncology Radiation OncologyMulti-institution Clinical StudyEngineeringMedical ImagingDiagnostic Imaging	2015	104
Five‐year analysis from phase 2 trial of “sandwich” chemoradiotherapy in newly diagnosed, stage <scp>IE</scp> to <scp>IIE</scp>, nasal type, extranodal natural killer/T‐cell lymphoma Li Zhang, Ming Jiang, Li Xie, Cancer Medicine	2015	46
PD-1 blockade with sintilimab plus induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) versus IC-CCRT in locoregionally-advanced nasopharyngeal carcinoma (LANPC): A multicenter, phase 3, randomized controlled trial (CONTINUUM). Jun Ma, Ying Sun, Xu Liu, Journal of Clinical Oncology OncologyPd-1 BlockadeClinical TrialsRecurrent/metastatic NpcHigh-risk Lanpc	2023	18

Page 1